Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
8233 ARTÍCULOS , VIENDO DEL 1306 AL 1320
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends
Coimbra JRM, Moreira PI, Santos AE, Salvador JAR.
Drug Discov Today. 2023 Oct;28(10):103644. doi: 10.1016/j.drudis.2023.103644. Epub 2023 May 26.
Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma
Anwar F, Al-Abbasi FA, Naqvi S, Sheikh RA, Alhayyani S, Asseri AH, Asar TO, Kumar V.
Int J Nanomedicine. 2023 May 22;18:2737-2756. doi: 10.2147/IJN.S405454. eCollection 2023.
COVID-19 and Alzheimer's Disease: The Link Finally Established
Fajloun Z, Wu Y, Cao Z, Kovacic H, Sabatier JM.
Infect Disord Drug Targets. 2023;23(7):14-16. doi: 10.2174/1871526523666230529162633.
Zhang J, Zheng X, Zhao Z.
BMC Neurol. 2023 May 31;23(1):210. doi: 10.1186/s12883-023-03191-w.
Is Vitamin D Supplementation a Danger to Potential Treatments of Alzheimer's Disease Treatment?
Shih PY, Yong SB, Liu CM, Cheng-Chung Wei J.
Curr Alzheimer Res. 2023;20(2):59-62. doi: 10.2174/1567205020666230530095421.
Crosstalk between Adult Hippocampal Neurogenesis and Its Role in Alzheimer's Disease
Tiwari V, Mishra A, Singh S, Shukla S.
ACS Chem Neurosci. 2023 Jun 21;14(12):2271-2281. doi: 10.1021/acschemneuro.3c00119. Epub 2023 Jun 1.
Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P.
Mol Psychiatry. 2023 Jun;28(6):2197-2214. doi: 10.1038/s41380-023-02113-z. Epub 2023 Jun 2.
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
García-Culebras A, Cuartero MI, Peña-Martínez C, Moraga A, Vázquez-Reyes S, de Castro-Millán FJ, Cortes-Canteli M, Lizasoain I, Moro MÁ.
Br J Pharmacol. 2024 Mar;181(6):777-798. doi: 10.1111/bph.16159. Epub 2023 Jul 7.
CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges
Chacko L, Chaudhary A, Singh B, Dewanjee S, Kandimalla R.
Drug Discov Today. 2023 Aug;28(8):103652. doi: 10.1016/j.drudis.2023.103652. Epub 2023 Jun 7.
Burns LH, Pei Z, Wang HY.
Drug Dev Res. 2023 Sep;84(6):1085-1095. doi: 10.1002/ddr.22085. Epub 2023 Jun 8.
Memantine induced encephalopathy in chronic kidney disease: a case report
Prasad P, Bagai S, Khullar D.
Postgrad Med J. 2023 Jun 8;99(1171):498-499. doi: 10.1136/postgradmedj-2022-141646.
Knopman DS, Hershey L.
Neurology. 2023 Oct 3;101(14):610-620. doi: 10.1212/WNL.0000000000207438. Epub 2023 Jun 9.
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease
Su M, Nizamutdinov D, Liu H, Huang JH.
Int J Mol Sci. 2023 May 25;24(11):9272. doi: 10.3390/ijms24119272.
Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs
Niu Y, Lin P.
Drug Discov Today. 2023 Aug;28(8):103665. doi: 10.1016/j.drudis.2023.103665. Epub 2023 Jun 9.
BACE-1 Inhibitors Targeting Alzheimer's Disease
Monteiro KLC, Dos Santos Alcântara MG, Freire NML, Brandão EM, do Nascimento VL, Dos Santos Viana LM, de Aquino TM, da Silva-Júnior EF.
Curr Alzheimer Res. 2023;20(3):131-148. doi: 10.2174/1567205020666230612155953.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.